Hartaj Singh Talks Moderna (MRNA) Earnings

Hartaj Singh, Equity Analyst at Oppenheimer, says that more governments are coming to Moderna for their manufacturing process and their efficacy. He adds that increased certainty in revenues in this year and next has helped increase the stock price.

ON AIR
7:00 am
Futures

Get Market Minute

Daily insights for every investor

FOLLOW US

Hartaj Singh Talks Moderna (MRNA) Earnings

Hartaj Singh, Equity Analyst at Oppenheimer, says that more governments are coming to Moderna for their manufacturing process and their efficacy. He adds that increased certainty in revenues in this year and next has helped increase the stock price.

ON AIR
7:00 am
Futures

Get Market Minute

Daily insights for every investor

FOLLOW US